{"public_id":"cl_6c2546eebe8c16d1583b7abbc4756657","status":"active","superseded_by_public_id":null,"corpus_id":156051226,"text":"Quality of life impairments were detected only for use of cocaine and anxiolytic drugs, with no significant impairments found for other substances tested.","confidence":0.92,"paper":{"corpus_id":156051226,"title":"Relationship between substance use and quality of life in a community sample of adults","url":"https://sah.borca.ai/papers/156051226"},"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.92,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":2},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_7afcd6a36bfcc907e6443eb76cd59824","name":"cocaine","description":"An illicit stimulant drug whose use was associated with quality of life impairments in this sample.","types":["substance"],"url":"https://sah.borca.ai/concepts/co_7afcd6a36bfcc907e6443eb76cd59824"},{"public_id":"co_e5b292842efd6aaa61506222a17e68f7","name":"quality of life","description":"A multidimensional measure of individuals' subjective well-being across distinct life domains, assessed here using the WHOQOL-bref instrument.","types":["outcome measure"],"url":"https://sah.borca.ai/concepts/co_e5b292842efd6aaa61506222a17e68f7"},{"public_id":"co_ec5b5ca727ae7bd4b061a0d0ed48e0c1","name":"anxiolytic drugs","description":"Pharmaceutical agents used to reduce anxiety, whose use was linked to quality of life impairments in this study.","types":["substance","drug class"],"url":"https://sah.borca.ai/concepts/co_ec5b5ca727ae7bd4b061a0d0ed48e0c1"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_6c2546eebe8c16d1583b7abbc4756657"}